JP2005204539A5 - - Google Patents

Download PDF

Info

Publication number
JP2005204539A5
JP2005204539A5 JP2004013291A JP2004013291A JP2005204539A5 JP 2005204539 A5 JP2005204539 A5 JP 2005204539A5 JP 2004013291 A JP2004013291 A JP 2004013291A JP 2004013291 A JP2004013291 A JP 2004013291A JP 2005204539 A5 JP2005204539 A5 JP 2005204539A5
Authority
JP
Japan
Prior art keywords
hematopoietic
cells
stem cells
amplification method
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004013291A
Other languages
English (en)
Japanese (ja)
Other versions
JP4651282B2 (ja
JP2005204539A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004013291A priority Critical patent/JP4651282B2/ja
Priority claimed from JP2004013291A external-priority patent/JP4651282B2/ja
Priority to PCT/JP2004/010677 priority patent/WO2005071064A1/ja
Priority to US10/587,014 priority patent/US8168429B2/en
Priority to CA2554192A priority patent/CA2554192C/en
Publication of JP2005204539A publication Critical patent/JP2005204539A/ja
Publication of JP2005204539A5 publication Critical patent/JP2005204539A5/ja
Application granted granted Critical
Publication of JP4651282B2 publication Critical patent/JP4651282B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004013291A 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法 Expired - Fee Related JP4651282B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2004013291A JP4651282B2 (ja) 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法
PCT/JP2004/010677 WO2005071064A1 (ja) 2004-01-21 2004-07-21 造血幹細胞及び造血前駆細胞の増幅方法
US10/587,014 US8168429B2 (en) 2004-01-21 2004-07-21 Method of amplifying hematopoietic stem cell and hematopoietic progenitor cell
CA2554192A CA2554192C (en) 2004-01-21 2004-07-21 Method of amplifying hematopoietic stem cell and hematopoietic progenitor cell

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004013291A JP4651282B2 (ja) 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法

Publications (3)

Publication Number Publication Date
JP2005204539A JP2005204539A (ja) 2005-08-04
JP2005204539A5 true JP2005204539A5 (enExample) 2007-03-08
JP4651282B2 JP4651282B2 (ja) 2011-03-16

Family

ID=34805380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004013291A Expired - Fee Related JP4651282B2 (ja) 2004-01-21 2004-01-21 造血幹細胞及び造血前駆細胞の増幅方法

Country Status (4)

Country Link
US (1) US8168429B2 (enExample)
JP (1) JP4651282B2 (enExample)
CA (1) CA2554192C (enExample)
WO (1) WO2005071064A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008073B2 (en) 2003-12-12 2011-08-30 Chugai Seiyaku Kabushiki Kaisha Anti-Mpl antibodies

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4921083B2 (ja) * 2005-09-13 2012-04-18 タカラバイオ株式会社 レトロウィルス産生用無血清培地
JPWO2007145227A1 (ja) * 2006-06-14 2009-11-05 中外製薬株式会社 造血幹細胞増加促進剤
WO2008009642A1 (en) * 2006-07-17 2008-01-24 Novozymes A/S Cell culture media
DK3117828T3 (da) 2007-09-11 2020-03-09 Univ Sapporo Medical Celleproliferationsfremgangsmåde og farmaceutisk lægemiddel til vævsreparation og -regenerering
EP2218716B1 (en) * 2007-12-06 2016-11-16 Nissan Chemical Industries, Ltd. Method for amplifying hematopoietic stem cells using heterocyclic compound
EP2270137A4 (en) 2008-03-11 2012-05-09 Riken METHOD FOR THE PRODUCTION OF CELLS WITH THE CHARACTERISTICS OF HEMATOPOETIC STEM CELLS / PRECURSOR CELLS
JP5737177B2 (ja) * 2009-06-04 2015-06-17 日産化学工業株式会社 ヘテロ環化合物及び造血幹細胞の増幅剤
US9315776B2 (en) 2011-11-09 2016-04-19 National University Of Singapore Wharton's jelly mesenchymal stem cells and uses thereof
SG11201501024QA (en) 2012-08-15 2015-03-30 Univ Singapore Wound dressing nanomesh impregnated with human umbilical cord wharton's jelly stem cells
US9402388B2 (en) * 2012-11-01 2016-08-02 National University Of Singapore Methods of freezing stem cells
JP2017532325A (ja) * 2014-10-03 2017-11-02 イエール ユニバーシティ 抗癌療法のための自然免疫系の改変
TWI548748B (zh) * 2015-04-16 2016-09-11 台灣尖端先進生技醫藥股份有限公司 造血幹／先驅細胞之體外放大培養方法及其立即可使用之組成物
US20180163177A1 (en) * 2016-12-11 2018-06-14 Healthbanks Biotech Co. Ltd. Serum-free culture medium and method for expanding hematopoietic stem cells
CN114686432B (zh) * 2020-12-28 2024-02-02 苏州方舟生物科技有限公司 一种中性粒细胞的高效扩增培养体系及其应用
US20240287458A1 (en) * 2021-06-30 2024-08-29 Regrow Biosciences Private Limited Method of obtaining hsc population, t cell population and nk cell population and compositions thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US5437994A (en) * 1989-06-15 1995-08-01 Regents Of The University Of Michigan Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5635386A (en) * 1989-06-15 1997-06-03 The Regents Of The University Of Michigan Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
IL110755A (en) 1993-08-23 2000-11-21 Nexell Therapeutics Inc In vitro growth of neutrophil and megakaryocyte precursors in serum-free media
US6037174A (en) * 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5505908A (en) * 1994-09-01 1996-04-09 Halozone Technologies, Inc. Recycling and recovery of methyl bromide fumigant
EP0891419A4 (en) 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
EP0937461B1 (en) * 1996-07-10 2005-07-06 Meiji Dairies Corporation Use of proteins from the mk family as hematopoietic factor
WO1998006822A1 (fr) * 1996-08-08 1998-02-19 Yoshitomi Pharmaceutical Industries, Ltd. Milieu de culture et ses applications
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
AU2003273332A1 (en) * 2002-09-26 2004-04-19 Children's Medical Center Corporation Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
WO2005070120A2 (en) * 2004-01-09 2005-08-04 Serologicals Investment Company, Inc. Cell culture media

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008073B2 (en) 2003-12-12 2011-08-30 Chugai Seiyaku Kabushiki Kaisha Anti-Mpl antibodies

Similar Documents

Publication Publication Date Title
JP2005204539A5 (enExample)
Flores-Guzmán et al. Concise review: ex vivo expansion of cord blood-derived hematopoietic stem and progenitor cells: basic principles, experimental approaches, and impact in regenerative medicine
Hong et al. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells
Ejtehadifar et al. The effect of hypoxia on mesenchymal stem cell biology
Dominici et al. Heterogeneity of multipotent mesenchymal stromal cells: from stromal cells to stem cells and vice versa
JP2008518603A5 (enExample)
JP2020089373A (ja) 幹細胞培養培地及び細胞生存を増強する方法
JP2010530214A5 (enExample)
JP2014516034A5 (enExample)
JP2018104457A (ja) 改善された造血幹細胞および前駆細胞療法
JP2015507921A5 (enExample)
HRP20120887T4 (hr) Adherentne stanice iz masnog i tkiva posteljice i njihova upotreba u terapiji
CN115335065A (zh) 细胞培养组合物及其用途
Mizukami et al. Efficient expansion of mesenchymal stromal cells in a disposable fixed bed culture system
Gastens et al. Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy
Česen Mazič et al. Treatment of severe steroid-refractory acute-graft-vs.-host disease with mesenchymal stem cells–single center experience
Valencic et al. The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation
JP2014527820A5 (enExample)
JP2014508527A5 (enExample)
Li et al. Biological characteristics of human placental mesenchymal stem cells and their proliferative response to various cytokines
WO2005068612A3 (en) Human hepatic progenitor cells and methods of use thereof
Zhao et al. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia
US20060286669A1 (en) Isolation of multi-lineage stem cells
WO2004078916A3 (en) In vitro micro-organs, and uses related thereto
EP2258833A3 (en) Isolation of a new cardiac stem cell population